UBS Group
RVMDW icon

UBS Group’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

UBS Group’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59K Buy
+886
New +$1.72K ﹤0.01% 9492
2025
Q1 		– Sell
-2,692
Closed -$485 – 10650
2024
Q4 		$485 Buy
2,692
+2,664
+9,514% +$788 ﹤0.01% 9453
2024
Q3 		$4 Sell
28
-447
-94% -$54 ﹤0.01% 9397
2024
Q2 		$48 Buy
475
+384
+422% +$80 ﹤0.01% 9236
2024
Q1 		$17 Sell
91
-880
-91% -$178 ﹤0.01% 9053
2023
Q4 		$320 Buy
+971
New +$434 ﹤0.01% 8728

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

UBS Group's RVMDW Position: Q1 2026 in Review

UBS Group opened a new position in Revolution Medicines Inc Warrant (RVMDW) in Q1 2026: 886 shares worth $1.59K. The stake represents ﹤0.01% of the portfolio and ranks #9492 among its holdings. This is a return to the name: UBS Group previously reported a position in RVMDW as recently as Q4 2024.

UBS Group first reported a position in RVMDW in Q4 2023 and has held it in 6 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • UBS Group held 886 shares of Revolution Medicines Inc Warrant worth $1.59K as of Q1 2026.
  • Revolution Medicines Inc Warrant was a new UBS Group position in Q1 2026.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9492 holding.
  • UBS Group first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 6 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.